Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. N-diethylmethylammoniummethyl-p-(2-(n-octyloxy)benzoyl)aminobenzoate Bromide
2. Octylonium
3. Octylonium Bromide
4. Octylonium Iodide
5. Spasmomen
1. 26095-59-0
2. Octylonium Bromide
3. Otilonium (bromide)
4. Sp63
5. Doralin
6. Spasmoctyl 40
7. 21hn3n72pv
8. Spasmomen
9. Sp-63
10. Otilonium Bromide (inn)
11. Diethyl(2-hydroxyethyl)methylammonium Bromide P-(o-(octyloxy)benzamido)-benzoate
12. Diethyl-methyl-[2-[4-[(2-octoxybenzoyl)amino]benzoyl]oxyethyl]azanium;bromide
13. Dsstox_cid_26357
14. Dsstox_rid_81559
15. Dsstox_gsid_46357
16. Otilonium Bromide [inn]
17. Otilonii Bromidum
18. Ottilonio Bromuro
19. N,n-diethyl-n-methyl-2-(4-(2-(octyloxy)benzamido)benzoyloxy)ethanaminium Bromide
20. Ottilonio Bromuro [italian]
21. Bromure D'otilonium
22. Bromuro De Otilonio
23. Otilonium Bromide [inn:ban]
24. Cas-26095-59-0
25. Otilonii Bromidum [inn-latin]
26. Bromure D'otilonium [inn-french]
27. Bromuro De Otilonio [inn-spanish]
28. Ncgc00163507-01
29. Einecs 247-457-4
30. Unii-21hn3n72pv
31. Octylonium Bromide;sp63
32. Diethyl(2-hydroxyethyl)methylammonium Bromide P-(o-(octyloxy)benzamido)benzoate
33. Ethanaminium, N,n-diethyl-n-methyl-2-((4-((2-(octyloxy)benzoyl)amino)benzoyl)oxy)-, Bromide
34. Mls006011208
35. Schembl109554
36. Otilonium Bromide [mi]
37. Chembl2103773
38. Dtxsid0046357
39. Hy-b0499a
40. Otilonium Bromide [mart.]
41. Hms3651l16
42. Hms3885i05
43. Otilonium Bromide [who-dd]
44. Bcp09737
45. Tox21_112059
46. Mfcd00211142
47. Otilonium Bromide, >=98% (hplc)
48. S3047
49. Akos015833077
50. Tox21_112059_1
51. Ccg-270064
52. Ks-1278
53. Ammonium, Diethyl(2-hydroxyethyl)methyl-, Bromide, P-(o-(octyloxy)benzamido)benzoate
54. N,n-diethyl-n-methyl-2-((4-(2-(octyloxy)benzamido)benzoyl)oxy)ethan-1-aminium Bromide
55. N,n-diethyl-n-methyl-2-((4-(2-(octyloxy)benzamido)benzoyl)oxy)ethanaminium Bromide
56. Ncgc00163507-03
57. Ethanaminium, N,n-diethyl-n-methyl-2-[[4-[[2-(octyloxy)benzoyl]amino]benzoyl]oxy]-, Bromide (1:1)
58. Smr004702974
59. Ft-0630523
60. Sw219209-1
61. D07083
62. Q920900
63. J-016250
64. J-523842
Molecular Weight | 563.6 g/mol |
---|---|
Molecular Formula | C29H43BrN2O4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 17 |
Exact Mass | 562.24062 g/mol |
Monoisotopic Mass | 562.24062 g/mol |
Topological Polar Surface Area | 64.6 Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 600 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
A03AB06
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03A - Drugs for functional gastrointestinal disorders
A03AB - Synthetic anticholinergics, quaternary ammonium compounds
A03AB06 - Otilonium bromide
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Otilonium Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Otilonium Bromide, including repackagers and relabelers. The FDA regulates Otilonium Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Otilonium Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Otilonium Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Otilonium Bromide supplier is an individual or a company that provides Otilonium Bromide active pharmaceutical ingredient (API) or Otilonium Bromide finished formulations upon request. The Otilonium Bromide suppliers may include Otilonium Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Otilonium Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Otilonium Bromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Otilonium Bromide active pharmaceutical ingredient (API) in detail. Different forms of Otilonium Bromide DMFs exist exist since differing nations have different regulations, such as Otilonium Bromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Otilonium Bromide DMF submitted to regulatory agencies in the US is known as a USDMF. Otilonium Bromide USDMF includes data on Otilonium Bromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Otilonium Bromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Otilonium Bromide suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Otilonium Bromide Drug Master File in Korea (Otilonium Bromide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Otilonium Bromide. The MFDS reviews the Otilonium Bromide KDMF as part of the drug registration process and uses the information provided in the Otilonium Bromide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Otilonium Bromide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Otilonium Bromide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Otilonium Bromide suppliers with KDMF on PharmaCompass.
A Otilonium Bromide written confirmation (Otilonium Bromide WC) is an official document issued by a regulatory agency to a Otilonium Bromide manufacturer, verifying that the manufacturing facility of a Otilonium Bromide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Otilonium Bromide APIs or Otilonium Bromide finished pharmaceutical products to another nation, regulatory agencies frequently require a Otilonium Bromide WC (written confirmation) as part of the regulatory process.
click here to find a list of Otilonium Bromide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Otilonium Bromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Otilonium Bromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Otilonium Bromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Otilonium Bromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Otilonium Bromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Otilonium Bromide suppliers with NDC on PharmaCompass.
Otilonium Bromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Otilonium Bromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Otilonium Bromide GMP manufacturer or Otilonium Bromide GMP API supplier for your needs.
A Otilonium Bromide CoA (Certificate of Analysis) is a formal document that attests to Otilonium Bromide's compliance with Otilonium Bromide specifications and serves as a tool for batch-level quality control.
Otilonium Bromide CoA mostly includes findings from lab analyses of a specific batch. For each Otilonium Bromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Otilonium Bromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Otilonium Bromide EP), Otilonium Bromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Otilonium Bromide USP).
LOOKING FOR A SUPPLIER?